Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects

Journal of Hypertension

Volumn 22, Issue 8, 2004, Pages 1623-1630

  De Luca, Nicola ^a   Asmar, Roland G ^b   London, Gérard M ^c   O'Rourke, Michael F ^d   Safar, Michel E ^e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b L'Institut CardioVasculaire   (France)

^c Ctr Hosp Frederick Henri Manhes   (France)

^d ST VINCENT S HOSPITAL   (Australia)

^e HÔTEL DIEU   (France)

Author keywords

Arrtihypertensive drug therapy; Arterial stiffness; Cardiac mass; Pulse pressure

Indexed keywords

ATENOLOL; INDAPAMIDE; PERINDOPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; ESSENTIAL HYPERTENSION; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 3843146120     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000125448.28861.fc     Document Type: Article

References (24)

1. Black HR. The paradigm has shifted, to systolic blood pressure. Hypertension 1999; 34:386-387.
2. Nichols WW, O'Rourke M. In: Nichols WW (editor): McDonald's blood flow in arteries: theoretical, experimental and clinical principles. London: Oxford University Press; 1998, pp. 54-113, 201-222, 284-292, 347-401.
3. O'Rourke MF, Nichols WW. Effect of ramipril on cardiovascular events in high-risk patients. N Engl J Med 2000; 343:64-66.
4. Asmar RG, London GM, O'Rourke MF, Mallion JM, Romero R, Rahn KH, et al. Amelioration of arterial properties with a perindopril/indapamide very-low-dose combination. J Hypertens 2001; 19(suppl 4):S15-S20.
5. Asmar RG, London GM, O'Rourke ME, Safar ME, and the REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 2001; 38:922-926.
6. London GM, Asmar RG, O'Rourke MF, Safar ME, on behalf of the REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapa mide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43:92-99.
7. Trimarco B, Ricciardelli B, De Luca N, De Simone A, Cuocolo A, Galva MD, et al. Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents. Circulation 1985; 72:38-46.
8. Trimarco B, De Luca N, Rosiello G, Ricciardelli B, Marchegiano R, Condorelli M, et al. Effects of long term antihypertensive treatment with tertatolol on diastolic function in hypertensive patients with and without left ventricular hypertrophy. Am J Hypertens 1989; 2:278S-283S.
9. London GM, Marchais SJ, Guerin AP, Metivier F, Safar ME, Fabiani F, et al. Salt and water retention and calcium blockade in uremia. Circulation 1990; 82:105-113.
10. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90: 2786-2796.
11. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50:600-608.
12. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitis O, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20:1251-1260.
13. Topouchian J, Asmar R, Sayegh F, Rudnicki A, Benetos A, Bacri AM, et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke 1999; 30:1056-1064.
14. Smulyan H, Siddiqui DS, Carlson RJ, London GM, Safar ME. Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension 2003; 42:150-155.
15. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16:2079-2084.
16. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000; 525:263-270.
17. Asmar R, Topouchian J, Pannier B, Benetos A, Safar M. Pulse wave velocity as end-point in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study. J Hypertens 2001; 19:813-818.
18. Lievre M, Gueret P, Gayet C, Roudaut R, Haugh MC, Delair S, et al. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. Hycar Study Group. Hypertension 1995; 25:92-97.
19. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:145-153.
20. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
21. Jennings G, Wong J. Regression of left ventricular hypertrophy in hypertension: changing patterns with successive meta-analyses. J Hypertens Suppl 1998; 16:S29-S34.
22. Nakayama Y, Tsumura K, Yamashita N, Yoshimaru K, Hayashi T. Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty. Circulation 2000; 101:470-472.
23. Nishijima T, Nakayama Y, Tsumura K, Yamashita N, Yoshimaru K, Ueda H, et al. Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease. Am J Hypertens 2001; 14:469-473.
24. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735-738.